Delivery of drugs to the brain via the blood brain barrier using colloidal carriers

References

• Abbott NJ, Patabendige AAK, Dolman DEM, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis 2010; 37: 13–25
   PubMed Web of Science ®Google Scholar
• Alavijeh MS, Chishty M, Qaiser MZ, Palmer AM. Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery. Neurorx 2005; 2: 554–71
   PubMedGoogle Scholar
• Albanese A, Sykes EA, Chan WCW. Rough around the edges: The inflammatory response of microglial cells to spiky nanoparticles. ACS Nano 2010; 4: 2490–3
   PubMed Web of Science ®Google Scholar
• Alexander JS, Zivadinov R, Maghzi AH, Ganta VC, Harris MK, Minagar A. Multiple sclerosis and cerebral endothelial dysfunction: Mechanisms. Pathophysiology 2011; 18: 3–12
   PubMedGoogle Scholar
• Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharmaceutics 2008; 5: 505–15
   PubMed Web of Science ®Google Scholar
• Armulik A, Genove G, Mae M, Nisancioglu MH, Wallgard E, Niaudet C, He L, Norlin J, Lindblom P, Strittmatter K, et al. Pericytes regulate the blood-brain barrier. Nature 2010; 468: 557–61
   PubMed Web of Science ®Google Scholar
• Bareford LM, Swaan PW. Endocytic mechanisms for targeted drug delivery. Adv Drug Delivery Rev 2007; 59: 748–58
   PubMed Web of Science ®Google Scholar
• Bell MA, Ball MJ. Morphometric comparison of hippocampal microvasculature in ageing and demented people: Diameters and densities. Acta Neuropathol 1981; 53: 299–318
   PubMed Web of Science ®Google Scholar
• Bertossi M, Maiorano E, Occhiogrosso M, Roncali L. Ultrastructural and morphometric investigation of human brain capillaries in normal and peritumoral tissues. Ultrastruct Pathol 1997; 21: 41–9
   PubMed Web of Science ®Google Scholar
• Bickel U. How to measure drug transport across the blood-brain barrier. Neurorx 2005; 2: 15–26
   PubMedGoogle Scholar
• Boero JA, Ascher J, Arregui A, Rovainen C, Woolsey TA. Increased brain capillaries in chronic hypoxia. J Appl Physiol 1999; 86: 1211–19
   PubMed Web of Science ®Google Scholar
• Brown WR, Thore CR. Review: Cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol 2011; 37: 56–74
   PubMed Web of Science ®Google Scholar
• Caputo KE, Hammer DA. Adhesive dynamics simulation of G-protein-mediated chemokine-activated neutrophil adhesion. Biophys J 2009; 96: 2989–3004
   PubMedGoogle Scholar
• Caputo KE, Lee D, King MR, Hammer DA. Adhesive dynamics simulations of the shear threshold effect for leukocytes. Biophys J 2007; 92: 787–97
   PubMedGoogle Scholar
• Carman AJ, Mills JH, Krenz A, Kim DG, Bynoe MS. Adenosine receptor signaling modulates permeability of the blood-brain barrier. J Neurosci 2011; 31: 13272–80
   PubMed Web of Science ®Google Scholar
• Carman CV, Sage PT, Sciuto TE, De La Fuente MA, Geha RS, Ochs HD, Dvorak HF, Dvorak AM, Springer TA. Transcellular diapedesis is initiated by invasive podosomes. Immunity 2007; 26: 784–97
   PubMed Web of Science ®Google Scholar
• Carmignoto G, Gomez-Gonzalo M. The contribution of astrocyte signalling to neurovascular coupling. Brain Res Rev 2010; 63: 138–48
   PubMed Web of Science ®Google Scholar
• Chang J, Jallouli Y, Kroubi M, Yuan XB, Feng W, Kang CS, Pu PY, Betbeder D. Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier. Int J Pharm 2009; 379: 285–92
   PubMed Web of Science ®Google Scholar
• Chapagain ML, Verma S, Mercier F, Yanagihara R, Nerurkar VR. Polyomavirus JC infects human brain microvascular endothelial cells independent of serotonin receptor 2A. Virology 2007; 364: 55–63
   PubMed Web of Science ®Google Scholar
• Charlier C, Nielsen K, Daou S, Brigitte M, Chretien F, Dromer F. Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun 2009; 77: 120–7
   PubMed Web of Science ®Google Scholar
• Chen H, Tang L, Qin Y, Yin Y, Tang J, Tang W, Sun X, Zhang Z, Liu J, He Q. Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery. Eur J Pharm Sci 2010; 40: 94–102
   PubMed Web of Science ®Google Scholar
• Cho EC, Zhang Q, Xia Y. The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. Nat Nanotechnol 2011; 6: 385–91
   PubMed Web of Science ®Google Scholar
• Cooper I, Malina KCK, Cagnotto A, Bazzoni G, Salmona M, Teichberg VI. Interactions of the prion peptide (PrP 106-126) with brain capillary endothelial cells: Coordinated cell killing and remodeling of intercellular junctions. J Neurochem 2011; 116: 467–75
   Google Scholar
• Debbage P, Thurner GC. Nanomedicine faces barriers. Pharmaceuticals 2010; 3: 3371–416
   Google Scholar
• Demeule M, Currie JC, Bertrand Y, Ché C, Nguyen T, Régina A, Gabathuler R, Castaigne JP, Béliveau R. Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2. J Neurochem 2008; 106: 1534–44
   PubMed Web of Science ®Google Scholar
• Dhuria SV, Hanson LR, Frey WHI. Intranasal delivery to the central nervous system: Mechanisms and experimental considerations. J Pharm Sci 2010; 99: 1654–73
   PubMed Web of Science ®Google Scholar
• Eugenin EA, Osiecki K, Lopez L, Goldstein H, Calderon TM, Berman JW. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: A potential mechanism of HIV-CNS invasion and NeuroAIDS. J Neurosci 2006; 26: 1098–106
   PubMed Web of Science ®Google Scholar
• Fang C, Shi B, Pei YY, Hong MH, Wu J, Chen HZ. In vivo tumor targeting of tumor necrosis factor-α-loaded stealth nanoparticles: Effect of MePEG molecular weight and particle size. Eur J Pharm Sci 2006; 27: 27–36
   PubMed Web of Science ®Google Scholar
• Fernandez-Klett F, Offenhauser N, Dirnagl U, Priller J, Lindauer U. Pericytes in capillaries are contractile in vivo, but arterioles mediate functional hyperemia in the mouse brain. Proc Natl Acad Sci USA 2010; 107: 22290–5
   PubMed Web of Science ®Google Scholar
• Freund JB, Orescanin MM. Cellular flow in a small blood vessel. J Fluid Mech 2011; 671: 466–90
   Google Scholar
• Gabathuler R. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol Dis 2010; 37: 48–57
   PubMed Web of Science ®Google Scholar
• Gao H, Shi W, Freund LB. Mechanics of receptor-mediated endocytosis. Proc Natl Acad Sci USA 2005; 102: 9469–74
   PubMed Web of Science ®Google Scholar
• Geng Y, Dalhaimer P, Cai S, Tsai R, Tewari M, Minko T, Discher DE. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol 2007; 2: 249–55
   PubMed Web of Science ®Google Scholar
• Georgieva JV, Kalicharan D, Couraud PO, Romero IA, Weksler B, Hoekstra D, Zuhorn IS. Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood-brain barrier endothelial cells in vitro. Mol Ther 2011; 19: 318–25
   PubMed Web of Science ®Google Scholar
• Golden PL, Maccagnan TJ, Pardridge WM. Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels. J. Clin Invest 1997; 99: 14–18
   Google Scholar
• Grab DJ, Garcia-Garcia JC, Nikolskaia OV, Kim YV, Brown A, Pardo CA, Zhang Y, Becker KG, Wilson BA, de A Lima AP, et al. Protease activated receptor signaling is required for African trypanosome traversal of human brain microvascular endothelial cells. PLoS Negl Trop Dis 2009; 3: e479
   Google Scholar
• Hakkarainen JJ, Jalkanen AJ, Kaariainen TM, Keski-Rahkonen P, Venäläinen T, Hokkanen J, Mönkkönen J, Suhonen M, Forsberg MM. Comparison of in vitro cell models in predicting in vivo brain entry of drugs. Int J Pharm 2010; 402: 27–36
   PubMed Web of Science ®Google Scholar
• Herve F, Ghinea N, Scherrmann JM. CNS delivery via adsorptive transcytosis. AAPS J 2008; 10: 455–72
   PubMed Web of Science ®Google Scholar
• Hijazi N, Kariv-Inbal Z, Gasset M, Gabizon R. PrPSc incorporation to cells requires endogenous glycosaminoglycan expression. J Biol Chem 2005; 280: 17057–61
   PubMed Web of Science ®Google Scholar
• Hillaireau H, Couvreur P. Nanocarriers’ entry into the cell: Relevance to drug delivery. Cell Mol Life Sci 2009; 66: 2873–96
   PubMed Web of Science ®Google Scholar
• Huang RB, Mocherla S, Heslinga MJ, Charoenphol P, Eniola-Adefeso O. Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review). Mol Membr Biol 2010b; 27: 190–205
   PubMed Web of Science ®Google Scholar
• Huang L, Sullenger B, Juliano R. The role of carrier size in the pharmacodynamics of antisense and siRNA oligonucleotides. J Drug Target 2010a; 18: 567–74
   PubMed Web of Science ®Google Scholar
• Jain A, Chasoo G, Singh SK, Saxena AK, Jain SK. Transferrin-appended PEGylated nanoparticles for temozolomide delivery to brain: In vitro characterisation. J Microencapsulation 2011; 28: 21–8
   PubMed Web of Science ®Google Scholar
• Jain SK, Paul-Satyaseela M, Lamichhane G, Kim KS, Bishai WR. Mycobacterium tuberculosis invasion and traversal across an in vitro human blood-brain barrier as a pathogenic mechanism for central nervous system tuberculosis. J Infect Dis 2006; 193: 1287–95
   PubMedGoogle Scholar
• Jeynes B, Provias J. The case for blood-brain barrier dysfunction in the pathogenesis of Alzheimer's disease. J Neurosci Res 2011; 89: 22–8
   PubMedGoogle Scholar
• Jogani V, Jinturkar K, Vyas TK, Misra A. Recent patents review on intranasal administration for CNS drug delivery. Recent patents on drug delivery and formulation 2008; 2: 25–40
   PubMedGoogle Scholar
• Jones AR, Shusta EV. Blood-brain barrier transport of therapeutics via receptor-mediation. Pharm Res 2007; 24: 1759–71
   PubMed Web of Science ®Google Scholar
• Jones AT. Gateways and tools for drug delivery: Endocytic pathways and the cellular dynamics of cell penetrating peptides. Int J Pharm 2008; 354: 34–8
   PubMed Web of Science ®Google Scholar
• Jong A, Wu CH, Prasadarao NV, Kwon-Chung KJ, Chang YC, Ouyang Y, Shackleford GM, Huang SH. Invasion of Cryptococcus neoformans into human brain microvascular endothelial cells requires protein kinase C-a activation. Cell Microbiol 2008a; 10: 1854–65
   PubMedGoogle Scholar
• Jong A, Wu CH, Shackleford GM, Kwon-Chung KJ, Chang YC, Chen HM, Ouyang Y, Huang SH. Involvement of human CD44 during Cryptococcus neoformans infection of brain microvascular endothelial cells. Cell Microbiol 2008b; 10: 1313–26
   PubMed Web of Science ®Google Scholar
• Kaminskas LM, McLeod VM, Porter HCJ, Boyd BJ. Differences in colloidal structure of PEGylated nanomaterials dictate the likelihood of accelerated blood clearance. J Pharm Sci 2011; 100(11): 5069–77
   Google Scholar
• Kandimalla KK, Scott OG, Fulzele S, Davidson MW, Poduslo JF. Mechanism of neuronal versus endothelial cell uptake of Alzheimer's disease amyloid beta protein. PLoS One 2009; 4: e4627
   PubMed Web of Science ®Google Scholar
• Karmali PP, Simberg D. Interactions of nanoparticles with plasma proteins: Implication on clearance and toxicity of drug delivery systems. Expert Opin Drug Deliv 2011; 8: 343–57
   PubMed Web of Science ®Google Scholar
• Ke W, Shao K, Huang R, Han L, Liu Y, Li J, Kuang Y, Ye L, Lou J, Jiang C. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. Biomaterials 2009; 30: 6976–85
   PubMed Web of Science ®Google Scholar
• Kim S, Kong RL, Popel AS, Intaglietta M, Johnson PC. Temporal and spatial variations of cell-free layer width in arterioles. Am J Physiol Heart Circ Physiol 2007; 293: H1526–35
   PubMed Web of Science ®Google Scholar
• Kreuter J, Shamenkov D, Petrov V, Ramge P, Cychutek K, Koch-Brandt C, Alyautdin R. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target 2002; 10: 317–25
   PubMed Web of Science ®Google Scholar
• Lam CK, Yoo T, Hiner B, Liu Z, Grutzendler J. Embolus extravasation is an alternative mechanism for cerebral microvascular recanalization. Nature 2010; 465: 478–82
   PubMed Web of Science ®Google Scholar
• LaManna JC, Chavez JC, Pichiule P. Structural and functional adaptation to hypoxia in the rat brain. J Exp Biol 2004; 207: 3163–9
   PubMed Web of Science ®Google Scholar
• Lee SY, Ferrari M, Decuzzi P. Design of bio-mimetic particles with enhanced vascular interaction. J Biomech 2009; 42: 1885–90
   PubMed Web of Science ®Google Scholar
• Ligade PC, Jadhav KR, Kadam VJ. Brain drug delivery system: An overview. Curr Drug Ther 2010; 5: 105–10
   Google Scholar
• Lokkegaard A, Nyengaard JR, West MJ. Stereological estimates of number and length of capillaries in subdivisions of the human hippocampal region. Hippocampus 2001; 11: 726–40
   PubMedGoogle Scholar
• Lossinsky AS, Shivers RR. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review. Histol Histopathol 2004; 19: 535–64
   PubMed Web of Science ®Google Scholar
• Maruvada R, Kim KS. Extracellular loops of the Escherichia coli outer membrane protein A contribute to the pathogenesis of meningitis. J Infect Dis 2010; 203: 131–40
   Google Scholar
• Meier-Ruge W, Hunziker O, Schulz U. Stereological changes in the capillary network and nerve cells of the aging human brain. Mech Ageing Dev 1980; 14: 233–43
   PubMedGoogle Scholar
• Mendu DR, Katinger H, Sodroski J, Kim KS. HIV-1 envelope protein gp140 binding studies to human brain microvascular endothelial cells. Biochem Biophys Res Commun 2007; 363: 466–71
   PubMedGoogle Scholar
• Miller DS. Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier. Trends Pharmacol Sci 2010; 31: 246–54
   PubMed Web of Science ®Google Scholar
• Mishra V, Mahor S, Rawat A, Gupta PN, Dubey P, Khatri K, Vyas SP. Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles. J Drug Target 2006; 14: 45–53
   PubMed Web of Science ®Google Scholar
• Nakaoke R, Ryerse JS, Niwa M, Banks WA. Human immunodeficiency virus type 1 transport across the in vitro mouse brain endothelial cell monolayer. Exp Neurol 2005; 193: 101–9
   PubMed Web of Science ®Google Scholar
• Nau R, Sorgel F, Eiffert H. Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 2010; 23: 858–83
   PubMed Web of Science ®Google Scholar
• Nguyen L, Pieters J. The Trojan horse: Survival tactics of pathogenic mycobacteria in macrophages. Trends Cell Biol 2005; 15: 269–76
   PubMed Web of Science ®Google Scholar
• Nikolskaia OV, Kim YV, Kovbasnjuk O, Kim KJ, Grab DJ. Entry of Trypanosoma brucei gambiense into microvascular endothelial cells of the human blood-brain barrier. Int J Parasitol 2006; 36: 513–9
   Google Scholar
• Oh P, Borgstrom P, Witkiewicz H, Li Y, Borgström BJ, Chrastina A, Iwata K, Zinn KR, Baldwin R, Testa JE, et al. Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol 2007; 25: 327–37
   PubMed Web of Science ®Google Scholar
• Pardridge WM. The blood-brain barrier: Bottleneck in brain drug development. NeuroRx 2005; 2: 3–14
   PubMedGoogle Scholar
• Pelkmans L, Kartenbeck J, Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol 2001; 3: 473–83
   PubMed Web of Science ®Google Scholar
• Peppiatt CM, Howarth C, Mobbs P, Attwell D. Bidirectional control of CNS capillary diameter by pericytes. Nature 2006; 443: 700–4
   PubMed Web of Science ®Google Scholar
• Pflanzner T, Janko MC, Andre-Dohmen B, Reuss S, Weggen S, Roebroek AJ, Kuhlmann CR, Pietrzik CU. LRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier. Neurobiol Aging 2011; 32: 2323.e111
   Google Scholar
• Potschka H. Targeting the brain - surmounting or bypassing the blood-brain barrier. Handb Exp Pharmacol 2010; 197: 411–31
   PubMedGoogle Scholar
• Predescu SA, Predescu DN, Malik AB. Molecular determinants of endothelial transcytosis and their role in endothelial permeability. Am J Physiol Lung Cell Mol Physiol 2007; 293: L823–42
   PubMed Web of Science ®Google Scholar
• Ragnaill MN, Brown M, Ye D, Bramini M, Callanan S, Lynch I, Dawson KA. Internal benchmarking of a human blood-brain barrier cell model for screening of nanoparticle uptake and transcytosis. Eur J Pharm Biopharm 2011; 77: 360–7
   PubMed Web of Science ®Google Scholar
• Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem J 2004; 377: 159–69
   PubMed Web of Science ®Google Scholar
• Ring A, Weiser JN, Tuomanen EI. Pneumococcal trafficking across the blood-brain barrier molecular analysis of a novel bidirectional pathway. J Clin Invest 1998; 102: 347–60
   PubMed Web of Science ®Google Scholar
• Rippe B, Rosengren BI, Carlsson O, Venturoli D. Transendothelial transport: The vesicle controversy. J Vasc Res 2002; 39: 375–90
   Google Scholar
• Sakhalkar HS, Dalal MK, Salem AK, Ansari R, Fu J, Kiani MF, Kurjiaka DT, Hanes J, Shakesheff KM, Goetz DJ. Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo. Proc Natl Acad Sci USA 2003; 100: 15895–900
   PubMed Web of Science ®Google Scholar
• Shin JS, Abraham SN. Caveolae as portals of entry for microbes. Microbes Infect 2001; 3: 755–61
   PubMed Web of Science ®Google Scholar
• Simone E, Ding BS, Muzykantov V. Targeted delivery of therapeutics to endothelium. Cell Tissue Res 2009; 335: 283–300
   PubMed Web of Science ®Google Scholar
• Simpson JE, Wharton SB, Cooper J, Gelsthorpe C, Baxter L, Forster G, Shaw PJ, Savva G, Matthews FE, Brayne C, et al. Alterations of the blood-brain barrier in cerebral white matter lesions in the ageing brain. Neurosci Lett 2010; 486: 246–51
   PubMed Web of Science ®Google Scholar
• Spector R, Johanson CE. Vectorial ligand transport through mammalian choroid plexus. Pharm Res 2010; 27: 2054–62
   PubMedGoogle Scholar
• Stamatovic SM, Keep RF, Andjelkovic AV. Brain endothelial cell-cell junctions: How to “open” the blood brain barrier. Curr Neuropharm 2008; 6: 179–92
   PubMed Web of Science ®Google Scholar
• Stewart PA. Endothelial vesicles in the blood-brain barrier: Are they related to permeability?. Cell Mol Neurobiol 2000; 20: 149–63
   PubMed Web of Science ®Google Scholar
• Teng CH, Cai M, Shin S, Xie Y, Kim KJ, Khan NA, Di Cello F, Kim KS. Escherichia coli K1 RS218 interacts with human brain microvascular endothelial cells via type 1 fimbria bacteria in the fimbriated state. Infect Immun 2005; 73: 2923–31
   PubMed Web of Science ®Google Scholar
• Thomas FC, Taskar K, Rudraraju V, Goda S, Thorsheim HR, Gaasch JA, Mittapalli RK, Palmieri D, Steeg PS, Lockman PR, et al. Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer. Pharm Res 2009; 26: 2486–94
   PubMed Web of Science ®Google Scholar
• Thorne RG, Lakkaraju A, Rodriguez-Boulan E, Nicholson C. In vivo diffusion of lactoferrin in brain extracellular space is regulated by interactions with heparan sulfate. Proc Natl Acad Sci USA 2008; 105: 8416–21
   PubMedGoogle Scholar
• Thorne RG, Nicholson C. In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space. Proc Natl Acad Sci USA 2006; 103: 5567–72
   PubMed Web of Science ®Google Scholar
• Triguero D, Buciak J, Pardridge WM. Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J Neurochem 1990; 54: 1882–8
   PubMed Web of Science ®Google Scholar
• Tucker IG. Drug delivery to the brain via the blood-brain barrier: A review of the literature and some recent patent disclosures. Ther Deliv 2011; 2: 311–27
   PubMedGoogle Scholar
• Unekawa M, Tomita M, Tomita Y, Toriumi H, Miyaki K, Suzuki N. RBC velocities in single capillaries of mouse and rat brains are the same, despite 10-fold difference in body size. Brain Res 2010; 1320: 69–73
   PubMedGoogle Scholar
• Van Rooy I, Cakir-Tascioglu S, Hennink WE, Storm G, Schiffelers RM, Mastrobattista E. In vivo methods to study uptake of nanoparticles into the brain. Pharm Res 2011; 28: 456–71
   PubMed Web of Science ®Google Scholar
• Vercauteren D, Vandenbroucke RE, Jones AT, Rejman J, Demeester J, De Smedt SC, Sanders NN, Braeckmans K. The use of inhibitors to study endocytic pathways of gene carriers: Optimization and pitfalls. Mol Ther 2010; 18: 561–9
   PubMed Web of Science ®Google Scholar
• Visser CC, Stevanovic S, Voorwinden LH, Gaillard PJ, Crommelin DJ, Danhof M, De Boer AG. Validation of the transferrin receptor for drug targeting to brain capillary endothelial cells in vitro. J Drug Target 2004; 12: 145–50
   PubMed Web of Science ®Google Scholar
• Von Wedel-Parlow M, Schrot S, Lemmen J, Treeratanapiboon L, Wegener J, Galla HJ. Neutrophils cross the BBB primarily on transcellular pathways: An in vitro study. Brain Res 2011; 1367: 62–76
   PubMedGoogle Scholar
• Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA. What the cell “sees” in bionanoscience. J Am Chem Soc 2010; 132: 5761–8
   PubMed Web of Science ®Google Scholar
• Wang BY, Xia AX, Chen PP, Ni L, Liu FH, Li FZ. Blood-brain barrier transport of drug-loaded nanoparticle: Research advances. J Int Pharm Res 2010; 37: 40–2
   Google Scholar
• Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P, et al. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005; 19: 1872–4
   PubMed Web of Science ®Google Scholar
• Wohlfart S, Khalansky AS, Gelperina S, Begley D, Kreuter J. Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier. J Controlled Release 2011; 154: 103–7
   PubMed Web of Science ®Google Scholar
• Yoo JW, Chambers E, Mitragotri S. Factors that control the circulation time of nanoparticles in blood: Challenges, solutions and future prospects. Curr Pharm Des 2010; 16: 2298–307
   PubMed Web of Science ®Google Scholar
• Zaki NM, Tirelli N. Gateways for the intracellular access of nanocarriers: A review of receptor-mediated endocytosis mechanisms and of strategies in receptor targeting. Expert Opin Drug Deliv 2010; 7: 895–913
   PubMed Web of Science ®Google Scholar
• Zeevi N, Pachter J, McCullough LD, Wolfson L, Kuchel GA. The blood-brain barrier: Geriatric relevance of a critical brain-body interface. J Am Geriatr Soc 2010; 58: 1749–57
   PubMed Web of Science ®Google Scholar
• Zensi A, Begley D, Pontikis C, Legros C, Mihoreanu L, Büchel C, Kreuter J. Human serum albumin nanoparticles modified with apolipoprotein A-I cross the blood-brain barrier and enter the rodent brain. J Drug Target 2010; 18: 842–8
   PubMed Web of Science ®Google Scholar
• Zensi A, Begley D, Pontikis C, Legros C, Mihoreanu L, Wagner S, Büchel C, von Briesen H, Kreuter J. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. J Controlled Release 2009; 137: 78–86
   PubMed Web of Science ®Google Scholar
• Zhang S, Li J, Lykotrafitis G, Bao G, Suresh S. Size-dependent endocytosis of nanoparticles. Adv Mater (Weinheim Ger) 2009; 21: 419–24
   PubMed Web of Science ®Google Scholar
• Zhou QH, Boado RJ, Lu JZ, Hui EKW, Pardridge WM. Re-engineering erythropoietin as an IgG fusion protein that penetrates the blood-brain barrier in the mouse. Mol Pharmaceutics 2010; 7: 2148–55
   PubMedGoogle Scholar